Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater!

J Clin Oncol. 2017 Jul 1;35(19):2213-2214. doi: 10.1200/JCO.2017.72.7776. Epub 2017 May 4.

Authors

Nicola Personeni¹, Lorenza Rimassa¹, Laura Giordano¹, Armando Santoro¹

Affiliation

¹ Nicola Personeni, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano; and University of Milan, Milan, Italy; Lorenza Rimassa and Laura Giordano, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy; and Armando Santoro, Humanitas Cancer Center, Humanitas Clinical and Research Center; and Humanitas University, Rozzano, Italy.

PMID: 28471708
DOI: 10.1200/JCO.2017.72.7776

No abstract available

Publication types

Letter
Comment

MeSH terms

Adult
Carcinoma, Hepatocellular*
Hepacivirus
Humans
Liver Neoplasms*
Sorafenib

Substances

Sorafenib